Lilly Said to Near Deal for Psychedelic Drugmaker AtaiBeckley

Eli Lilly & Co. is in talks to acquire psychedelic drugmaker AtaiBeckley Inc.

The deal highlights large drugmaker interest in psychedelic medicine.

No final agreement has been reached, according to people familiar with the matter.